Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Even light-intensity activities such as walking can reduce one’s risk for clinical depression. So, what are the most common ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Now, a new crop of buzzy non-invasive VNS gadgets promises to relieve stress, sharpen focus and improve sleep in mere minutes ...

Discover the difference between burnout vs depression, including causes, symptoms, and how both are treated, according to ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...

The winter blues, on the other hand, are less serious. They usually don’t involve thoughts of hopelessness or suicide, but ...

The 19-year-old, who is the youngest daughter of Charlie Sheen and Denise Richards, revealed that her “deep depression” led ...

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...